The biotech property boom in the nation's top life science market of Boston isn't slowing demand for the country's No. 2 spot, the San Francisco Bay Area, as Alexandria Real Estate Equities and developer Boston Properties embark on a 1.7 million-square-foot life science campus in South San Francisco.